Hey everybody we're Avmauer here and today we're going to be talking a little bit about

Tesla's research and development expenditures, for some reason this is popped up as a topic

today so I wanted to share my thoughts.

Also talk about a note from Goldman Sachs, this was from earlier this week on Tuesday,

but there are some interesting items in there that I wanted to discuss, also got an update

on Tesla's handling of the prioritization of FSD orders, news from LG on another battery

factory, an update on Elon Musk's board position on another company, and then a scheduling

note at the end.

Alright so Tesla's stock streak has continued, this is the 8th trading day in a row that

Tesla has finished positive up 1.5% today to $1,013.92, this did trail a little bit behind

the NASDAQ we'll take it given the overperformance of the last week or so, but the NASDAQ with a strong

day to day finishing up 1.9%.

We're now getting to the point where we can start to keep an eye on if this might become

the longest streak ever for Tesla for context, that was back in January of 2021, 11 trading

days in a row finishing positive, so we'll see if Tesla can match that, that'd be Friday

Monday and Tuesday, as we head into the last week here of the first quarter.

Alright so first up today I want to spend a second talking about Tesla's research and

development expenditures, or whatever reason this has been a topic covered by a bear

ins, electrax and others today, they're citing new research on this from some stock

blog, which I don't know why it's really presented as research because it's literally

just taking Tesla's R&D expenditures from their quarterly filing and dividing it by the

number of vehicles sold and then doing the same for other automakers, and then using that

...